Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib
NCT00335881 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2016-10-07
Summary
Persistence of seroprotective antibody concentrations \& immunological memory shown by the ability to mount a response to a challenge dose of HBV vaccine
Conditions
Interventions
- BIOLOGICAL
-
hepatitis B vaccine
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 4 Years
- Max Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-06-30
- Completion
- 2006-11-30
Countries
- Germany
Study Locations
More Related Trials
-
Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine
NCT00329576 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children
NCT01138098 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder
NCT01847430 ·Status: COMPLETED ·Phase: PHASE4
-
Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs
NCT00343915 ·Status: COMPLETED ·Phase: PHASE3
-
Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge
NCT00411697 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy
NCT02798952 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-B
NCT02901951 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers
NCT02153320 ·Status: COMPLETED ·Phase: PHASE1
-
Adolescents' Response to Hepatitis B Vaccine Booster Dose
NCT01341275 ·Status: UNKNOWN ·Phase: PHASE4
-
Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib Vaccine
NCT00880477 ·Status: COMPLETED ·Phase: PHASE3
-
Immunity to Hepatitis B Vaccine
NCT03083158 ·Status: COMPLETED ·Phase: PHASE4
-
Duration of Long-term Immunity After Hepatitis B Virus Immunization
NCT01182311 ·Status: COMPLETED
-
A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults
NCT02203357 ·Status: COMPLETED ·Phase: PHASE4
-
The Immunogenicity and Safety of 60mcg/30mcg Recombinant Hepatitis B Vaccines in People Who Failed to Respond to Routine Administration of Hepatitis B Vaccines
NCT01203319 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule
NCT00289744 ·Status: COMPLETED ·Phase: PHASE3
-
Hepatitis B Vaccine Clinical Trial
NCT00000583 ·Status: COMPLETED ·Phase: PHASE3
-
Protectivity and Safety Following Recombinant Hepatitis B Vaccine
NCT03919578 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years
NCT00383591 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years
NCT00197119 ·Status: COMPLETED ·Phase: PHASE3
-
A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination (V419-013)
NCT04490499 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule
NCT00289718 ·Status: COMPLETED ·Phase: PHASE3
-
Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED)
NCT00393523 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection
NCT03866187 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine
NCT00197171 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™
NCT00875485 ·Status: COMPLETED ·Phase: PHASE4